⌕
Adlai Nortye Group · ANL · Nasdaq
Tenet — · insufficient data
Compare
$8.74−7.81%At close
$8.74−0.74 (−7.81%)
At close: Nov 18, 2026, 4:00 PM ET· Nasdaq · USD
Data under review. Our nightly checks found a problem in this company's reported figures on Oct 23, 2026, so we are not showing its score, ratios or statements for now. The figures come back after they pass the checks two nights in a row. The price and chart are live.

Adlai Nortye Group (ANL) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is ANL's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● GlobeNewsWireOct 27, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Adlai Nortye Announces Oral Presentation for AN4035 Program Update at the Upcoming 38th EORTC-NCI-AACR Symposium

AN4035 late-breaking abstract selected for an oral presentation at the upcoming ENA Symposium in Barcelona Oral presentation will include translational and EGFR combination data for first-in-class AN4035 AN4035 is a nove…

ANL −7.8% todayRead at source ↗
● GlobeNewsWireOct 15, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab

AN4035, a first-in-class investigational pan-RAS(ON) inhibitor-based ADC, will be evaluated as monotherapy and in combination with cetuximab in the ongoing global Phase I trial…

ANL −7.8% todayRead at source ↗
● Zacks Investment ResearchOct 14, 2026 · 10:41 ET
Is Adlai Nortye Ltd. Sponsored ADR (ANL) Stock Outpacing Its Medical Peers This Year?

Here is how Adlai Nortye Ltd. Sponsored ADR (ANL) and Thermo Fisher Scientific (TMO) have performed compared to their sector so far this year.…

ANL −7.8% todayRead at source ↗
● GlobeNewsWireSep 30, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations

SINGAPORE and NORTH BRUNSWICK, N.J., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Group Ltd. (NASDAQ: ANL) (“Adlai Nortye” or the “Company”), a clinical-stage biotechnology company focused on the development of innova…

ANL −7.8% todayRead at source ↗
● Defense WorldSep 30, 2026 · 06:15 ET
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Stock Has Consensus Target Price of $29.50 According to Analysts

Shares of Adlai Nortye Ltd. Sponsored ADR (NASDAQ: ANL - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seven research firms that are covering the stock, MarketBeat.com reports. One …

ANL −7.8% todayRead at source ↗
● GlobeNewsWireSep 8, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC

First-in-class CEACAM5-targeting ADC armed with a pan-RAS(ON) inhibitor – designed for tumor-selective RAS pathway inhibition First patient dosed in Australia; global Phase I initiated U.S. FDA cleared IND with "Study-Ma…

ANL −7.8% todayRead at source ↗

No upcoming events in the feeds.

NVDA16−2.9%
ANT13
MSFT5+0.4%
P4−1.0%

Article counts from the last market-wide feed page, across every symbol we track and not just ANL · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.